您的位置: 专家智库 > >

国家自然科学基金(81072593)

作品数:2 被引量:5H指数:2
相关作者:吴美霖陆伟跃王飞黄园更多>>
相关机构:复旦大学四川大学更多>>
发文基金:国家教育部博士点基金国家自然科学基金国家重点基础研究发展计划更多>>
相关领域:医药卫生更多>>

文献类型

  • 2篇期刊文章
  • 2篇会议论文

领域

  • 4篇医药卫生

主题

  • 3篇LY
  • 2篇脂质体
  • 2篇肿瘤
  • 2篇肿瘤靶向
  • 2篇靶向
  • 2篇P-
  • 2篇LIPOSO...
  • 1篇多柔比星
  • 1篇脂质体制备
  • 1篇肿瘤治疗
  • 1篇淋巴
  • 1篇淋巴转移
  • 1篇介导
  • 1篇MULTID...
  • 1篇PHARMA...
  • 1篇TARGET...
  • 1篇TUMOR
  • 1篇AMIDE
  • 1篇CONJUG...
  • 1篇CYCLIC

机构

  • 2篇复旦大学
  • 1篇四川大学
  • 1篇国家工程研究...

作者

  • 1篇闫志强
  • 1篇黄园
  • 1篇王飞
  • 1篇王飞
  • 1篇陆伟跃
  • 1篇吴美霖

传媒

  • 1篇中国医药工业...
  • 1篇Asian ...

年份

  • 3篇2013
  • 1篇2011
2 条 记 录,以下是 1-4
排序方式:
Folic acid-conjugated liposomal vincristine for multidrug resistant cancer therapy被引量:3
2013年
We encapsulated vincristine into folic acid-conjugated PEGylated liposomes to improve the anti-tumor efficacy on multidrug resistant cancers.It was observed that the drug delivery system we constructed exhibited maximum cytotoxicity on KBv200 cells(multidrug resistant variant)compared with any other formulations.The semi-quantitative analysis of region of interest revealed that there was a great increase in area under curve(AUC)of a near-infrared fluorescein in solid tumors due to folic acid-mediated accumulation.Folic acid-conjugated PEGylated liposomes showed a significant tumor growth inhibiting effect in vitro and in vivo.TUNEL assay revealed that folic acid-conjugated PEGylated liposomes could induce cell apoptosis much more greatly than others.This study demonstrated that it had potential application prospective for the treatment of multidrug resistant cancer.
Chenyu WangLinglin FengXiangkun YangFei WangWeiyue Lu
关键词:LIPOSOMEVINCRISTINEPHARMACODYNAMICS
LyP-1介导的淋巴转移肿瘤靶向脂质体递药系统研究
引言淋巴转移肿瘤是实体瘤转移的重要途径,也是肿瘤难于治愈的主要原因[1-3]。肿瘤原发灶和转移淋巴结处的淋巴管新生极大地促进了肿瘤的淋巴转移[4]。LyP-1是通过噬菌体展示技术筛选
闫志强王飞魏晓丽俸灵林何丹农陆伟跃
文献传递
Improved liposomal tumor delivery targeted by cyclic amide-bonded c(LyP-1)
<正>Peptides have been widely used as targeting ligands to facilitate the tumor targeting of nanocarrier system...
Fei WangMeilin WuXiaoyu ZhangCao XieWeiyue Lu
文献传递
LyP-1修饰的肿瘤靶向脂质体制备及抗肿瘤活性评价被引量:2
2013年
利用固相合成法合成了LyP-1,一种对肿瘤细胞具有靶向能力的环状九肽,及其荧光素标记物(LyP-1-FAM)。利用巯基和马来酰亚胺的专属性反应制备了功能化脂质材料LyP-1-PEG 3400-DSPE。用成膜水化法制备了LyP-1修饰的多柔比星(1)、荧光素(FAM)和近红外染料(DiR)脂质体,并评价其对SCI 375黑素瘤细胞的体内外靶向性、细胞毒性和体内抑瘤效果。体外试验表明,SCI 375细胞对LyP-1-FAM或LyP-1修饰的FAM脂质体的摄取显著高于5-FAM或普通FAM脂质体。LyP-1修饰及未修饰的DiR脂质体分别尾静脉注射给予荷瘤裸鼠后,可见LyP-1修饰组肿瘤组织的荧光强度较高,提示DiR脂质体经LyP-1修饰后体内靶向性提高。LyP-1修饰及未修饰的1脂质体在体外对SCI 375细胞的IC50分别为3.4×10-6和8.0×10-6mol/L;修饰组在荷瘤裸鼠体内的抑瘤效果也显著高于未修饰组(P<0.05)。
吴美霖王飞黄园陆伟跃
关键词:脂质体多柔比星肿瘤靶向肿瘤治疗
共1页<1>
聚类工具0